Navigation Links
Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
Date:2/14/2011

sal osteoporosis later this year, and a Marketing Authorization Application to the European Medicines Agency next year.

Calcitonin is currently approved for the treatment of postmenopausal osteoporosis, but its use has been limited by the fact that it is currently available only in intranasal and injectable forms.  Tarsa's oral calcitonin product has been shown in prior clinical studies to deliver the desired blood levels of calcitonin and reduce levels of biomarkers of bone resorption.  

Dr. David Krause, Chief Medical Officer of Tarsa, commented, "Osteoporosis is a common condition that poses major health risks to individuals as they age, but it can be both treated and prevented.  Calcitonin has a long history of safety and efficacy as an osteoporosis therapy, and we believe the availability of Tarsa's easy-to-use, once-daily oral calcitonin tablet will be welcomed by the many health care providers and patients seeking additional treatment options, especially in view of continuing concerns about potential long-term safety issues with other popular classes of osteoporosis drugs."

Tarsa's Phase II prevention trial will also explore the optimal dosing regimen for oral calcitonin by administering the tablets either with the evening meal or at bedtime.  Calcitonin helps maintain bone mass by acting on osteoclasts to limit bone resorption.  Most bone resorption occurs while individuals are sleeping; therefore some researchers believe that nighttime administration would be ideal for an anti-resorptive agent such as calcitonin.  

For more information on the Phase II osteoporosis prevention trial, visit: http://www.clinicaltrials.gov/ct2/show/NCT01292187?term=tarsa&rank=2

About Tarsa TherapeuticsTarsa Therapeutics is developing an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteo
'/>"/>

SOURCE Tarsa Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
2. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
3. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigalâ„¢ Co-administered with Enzyme Replacement Therapy
4. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
5. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
6. DSM and NKT Therapeutics Sign Contract for Lead Product Development and Manufacture
7. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
8. Amarin to Present at the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
9. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
10. PTC Therapeutics and Parent Project Muscular Dystrophy Advance Drug Discovery Program to Improve Heart Function in Duchenne/Becker Muscular Dystrophy Patients
11. Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Varian Medical Systems (NYSE: VAR) today broke ... Salt Lake City manufacturing facility and allow ... Utah to ultimately create 1,000 new full ... " Utah is home ... of whom can be credited with Varian,s success in the ...
(Date:8/27/2014)... , August 27, 2014 ... Equipment Market By Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental ... published by MarketsandMarkets, the global Dental Equipment Market is ... $5,416.3 million in 2014, growing at a CAGR ... Browse 95 market data tables and 61 figures ...
(Date:8/27/2014)... August 27, 2014 ResearchMoz presents ...  Laparoscopes Market Outlook to 2020. New report, "United ... data on the United States Laparoscopes market . ... volume (in units) and average prices (in US dollars) ... and Flexible Tip Video Laparoscopes), Robotic Surgical Systems and ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 2United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 3United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 4United States Laparoscopes Market Outlook, Analysis, Size, Share, Growth, Trends And Forecast 2020 5
... CHERRY HILL, N.J., Nov. 20 New Jersey American Water has lifted the precautionary boil water advisory for its ... , , Dunellen , ... South Plainfield , , , , ... Bridgewater , Green Brook , ...
... announced today that the Anti-infective Drugs Advisory Committee ... voted 17 to 2 against the,approval of intravenous ... of patients with complicated skin and skin structure ... , Arpida ...
Cached Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4
(Date:8/27/2014)... York, New York (PRWEB) August 27, 2014 ... be filed in U.S. courts on behalf of women ... to uterine morcellation, Bernstein Liebhard LLP reports. According to ... filed on August 18th in the U.S. District Court, ... hysterectomy patient who claims the use of a power ...
(Date:8/27/2014)... 27, 2014 When Jagger was 20 years ... his mother; one that he credits as one of the ... had news that she could set him up with a ... disabilities. Jagger took that job, and he has now spent ... past two decades, he also worked in school boards, employment ...
(Date:8/27/2014)... Amy Norton HealthDay Reporter ... who take part in clinical trials of new heart disease ... patient, a new study confirms. Experts said the findings, ... American Medical Association , aren,t surprising -- but they are ... enrolling a more select patient population that is not fully ...
(Date:8/27/2014)... spending for commercially insured individuals is due primarily to ... use, according to a new study led by researchers ... Practice, published in the August issue of the ... increasing concern that consolidation in the health care marketplace ... ultimately, consumers," said Carrie Colla, PhD, assistant professor at ...
(Date:8/27/2014)... Scientists at The Scripps Research Institute (TSRI) have ... can be associated with alcohol dependence. , This ... type 1 (Nf1), which TSRI scientists found is linked ... Nf1 regulates gamma-aminobutyric acid (GABA), a neurotransmitter that lowers ... novel and seminal study provides insights into the cellular ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 2Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 3Health News:Fitness on the Go Expands into Liberty Village, City Place and Harbourfront Communities 4Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 2Health News:Heart Studies Don't Reflect Real-World Patients, Study Finds 3Health News:Tracking spending among the commercially insured 2Health News:Scripps Research Institute scientists link alcohol-dependence gene to neurotransmitter 2
... treated with genetically modified T cells remain healthy up to ... of Medicine at the University of Pennsylvania report in the ... provide a framework for the use of this type of ... HIV, cancer, and a wide variety of other diseases. ...
... researchers have succeeded in developing a biosynthetic polyphenol that ... The findings, published in a recent issue of the ... the feasibility of biosynthetic polyphenols as a possible therapy ... which there is currently no cure. Polyphenols, which ...
... WEDNESDAY, May 2 (HealthDay News) -- Chemistry in three ... a new, small study says. Along with providing ... could prove important in finding ways to treat depression, ... linked with decreased motivation, Vanderbilt University researchers said. ...
... past decade, there has been a steady stream of ... According to Dr. Louise Moist, a Scientist at Lawson ... for kidney patients undergoing hemodialysis. Hemodialysis can ... to join an artery to a vein. Unfortunately, AV ...
... , Houston, TX - Accelerated partial breast irradiation ... growing increasingly popular as a treatment choice for ... higher rate of later mastectomy, increased radiation-related toxicities ... irradiation (WBI), according to researchers from The University ...
... depression among patients with hepatitis C, but a standard ... can cause depression. In a review article, researchers ... and after initiating treatment with interferon. Dr. Murali ... co-author of the study, published in the International ...
Cached Medicine News:Health News:Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients 2Health News:Genetically modified T cell therapy shown to be safe, lasting in decade-long study of HIV patients 3Health News:Biosynthetic grape-derived compound prevents progression of Alzheimer's disease in mice 2Health News:Clues to 'Slacker' Behavior Found in Brain, Study Says 2Health News:Everyday fish oil capsule may provide kidney-related benefits 2Health News:APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation 2Health News:APBI associated with more mastectomies, toxicities, complications, compared to traditional radiation 3Health News:Hepatitis C drug can cause depression 2
Disposable Microscissors: Horizontal, Straight...
Low profile, sharp-tipped scissors with a vertical cutting action. Excellent for peeling and cutting fine epiretinal membranes....
... original and very popular 1286 ... cutting in the vertical plane ... tips allow greater versatility when ... Tip is shaped like pic ...
Claes Shielded Retinotomy Scissors, Curved Vertical...
Medicine Products: